Smalley K S, Koenig J A, Feniuk W, Humphrey P P
Glaxo Institute of Applied Pharmacology, Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QJ, UK.
Br J Pharmacol. 2001 Mar;132(5):1102-10. doi: 10.1038/sj.bjp.0703896.
There is controversy as to whether somatostatin sst(4) receptors internalize. In this study, CHO-K1 cells expressing human sst(4) receptor (CHOsst(4) cells) cells internalized [(125)I]-[(11)Tyr]-SRIF in a time-dependent manner, reaching a steady state at 60 min (1.4+/-0.1x10(4) molecules internalized per cell). Internalization was blocked by hypertonic sucrose (0.5 M), ATP depletion or by decreasing the temperature to 4 degrees C. Internalization of [(125)I]-[(11)Tyr]-SRIF was also inhibited (pIC(50) values) by increasing concentrations of SRIF (7.74), L-362855 (6.27) and NNC-296100 (6.50) with pIC(50) values approximately 10 fold lower than those obtained for inhibition of [(125)I]-[(11)Tyr]-SRIF binding to membrane homogenates. Internalized ligand recycled rapidly to the extracellular media (t(1/2) 3.9+/-0.7 min) with only 6.8+/-0.6% of internalized radioactivity remaining in the cell after 45 min. Confocal microscopy of permeabilized, HA-epitope tagged CHOsst(4) cells labelled with a Cy-3 conjugated antibody revealed little internal immunostaining after SRIF (1 microM) treatment, consistent with the small proportion of receptors (3.5%) estimated to be internalized by radioimmunoassay. In summary, CHOsst(4) cells internalized [(125)I]-[(11)Tyr]-SRIF in a clathrin- and ATP-dependent manner with subsequent rapid recycling to the extracellular medium. Rapid receptor recycling and the consequent low proportion of receptors internalized at any one time may explain the inability to visualize internalized receptors by confocal microscopy. It seems unlikely therefore that the marked receptor desensitization observed in CHOsst(4) cells following SRIF treatment can be accounted for by a decrease in cell surface receptor expression.
关于生长抑素sst(4)受体是否会发生内化存在争议。在本研究中,表达人sst(4)受体的CHO-K1细胞(CHOsst(4)细胞)以时间依赖性方式内化[(125)I]-[(11)Tyr]-生长抑素释放抑制因子,在60分钟时达到稳态(每个细胞内化1.4±0.1×10(4)个分子)。高渗蔗糖(0.5 M)、ATP耗竭或温度降至4℃可阻断内化。[(125)I]-[(11)Tyr]-生长抑素释放抑制因子的内化也受到生长抑素释放抑制因子(7.74)、L-362855(6.27)和NNC-296100(6.50)浓度增加的抑制(pIC(50)值),其pIC(50)值比抑制[(125)I]-[(11)Tyr]-生长抑素释放抑制因子与膜匀浆结合所获得的值低约10倍。内化的配体迅速循环至细胞外培养基(半衰期3.9±0.7分钟),45分钟后只有6.8±0.6%的内化放射性留在细胞内。用Cy-3偶联抗体标记的经通透处理的HA表位标签CHOsst(4)细胞的共聚焦显微镜检查显示,生长抑素释放抑制因子(1 microM)处理后细胞内免疫染色很少,这与放射免疫测定估计的内化受体的小比例(3.5%)一致。总之,CHOsst(4)细胞以网格蛋白和ATP依赖的方式内化[(125)I]-[(11)Tyr]-生长抑素释放抑制因子,随后迅速循环至细胞外培养基。快速的受体循环以及因此在任何时候内化的受体比例较低,可能解释了通过共聚焦显微镜无法观察到内化受体的原因。因此,在生长抑素释放抑制因子处理后在CHOsst(4)细胞中观察到的明显受体脱敏似乎不太可能是由于细胞表面受体表达的减少。